Elshad Hasanov, MD, PhD
@HasanovLab
Physician-Scientist @OSUCCC_James in #GU cancers #brainmet | PI #HasanovLab @OhioStatePIIO #spatialsinglecell | former fellow @MDAndersonNews | #cancerfreeworld
Blessed to have an incredible clinic, lab team, and collaborators. This holiday season, we came together to paint our shared vision for the future: a colorful, beautiful, and healthy brain—free of metastasis. Grateful for this talented, passionate, and committed team making this…

Congratulation to Dr. Marston Linehan on receiving the inaugural Kidney Cancer Hall of Fame award from @kidneycan at #KCRS25. A mentor to many of us and an inspiration to all in the kidney cancer community.
Big sis @NazliDizman presented an innovative trial evaluating the first bispecific PDL1/VEGF targeting agent Always one step ahead! Looking forward to seeing results! @OncoAlert
Lindsey Byrne discussing genetic testing for RCC at #KCRS25. @OSUWexMed @OSUCCC_James @OSU_Urology
Bright future ahead for kidney cancer with tumor neoantigen vaccine, inducing ferroptosis, KIM-1 biomarker, dual targeting CAIX/CD70 CAR-T cell. A great session at @kidneycan #KCRS25 by @EJonasch #CherylWalker @BraunMDPhD #MeiKoh #WayneMarasco @VincentWenxinXu


@KimrynRathmell delivering the keynote address at #KCRS25. @OSUWexMed @OSUCCC_James @OSU_Urology @kidneycan
Inspiring Keynote speech from @KimrynRathmell at @kidneycan #KCRS25: “The bottom line is we need more people going into science, and open doors to engage the public in partnership.” @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc @Pelotonia @eric_facs




🤗 We're excited to have our friend @KimrynRathmell @OSUCCC_James join us for a conversation about leadership and career building during our Women in RCC Summer Webinar! 📆 August 14 🕰️ 7:00-8:00 pm ET 👉 Register: bit.ly/3Gf9wgV #kidneycancer #womeninscience
Great discussions and questions at the panel debate on the #ASCO25 Review at @OhioStateMedOnc @lingbin_meng @AsrarAlahmadi @LoganRoofMD @HasanovLab @DCarboneMD @AshishManne @OSUCCC_James
Starting the day with #ASCO25 Review at @OhioStateMedOnc with an stellar lineup of speakers with our chairs @AsrarAlahmadi & @AshishManne a great opportunity for an update and networking with our colleagues from Ohio! @LoganRoofMD @lingbin_meng @HasanovLab @OSUCCC_James
Proud to be part of this pivotal trial and to have learned so much from Dr. Srinivasan and our patients. @theNCI @OSUCCC_James @OSU_Urology @KimrynRathmell @KidneyCancer @kidneycan @IKCCorg @KidneyCancer_Ca
🚨 Wow! #ASCO25 @ASCO was absolutely massive! 10 @NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert
🚨Update Randomized Trial: Significantly Better KPS & Cognitive Function with SRS compared to HA-WBRT for 5-20 brain mets 🚨🚨🚨
The FY26 HHS Budget in Brief has been released. It outlines how the existing NIH institutes & centers will be combined into eight (with only NCI, NIA & NIAID retaining their original structure). There are 40% cuts proposed in NIH budget (including the NCI). 😢 Cancer Research 📉
Check our presentations, meet the experts at the booth and more ! OSUCCC The James at #ASCO25! @OSUCCC_James @OhioStateMedOnc See you all in Chicago!! cancer.osu.edu/for-cancer-res…
Division Director @ChristianRolfo welcomes you all to join @OSUCCC_James and @OhioStateMedOnc at #ASCO25 and learn about ways to #BeABuckeye 🌰 youtube.com/watch?v=ufgygH…
From surveillance to surgery, Eric Singer, MD, MS, explains how @OhioState kidney cancer experts provide patients with the latest techniques and treatments to save and improve lives.
Ab#4506 @ASCO #ASCO25 by @DrChoueiri👉bit.ly/3H57gZC👉Results from Ph 1 ARC-20 study #kidneycancer👉Casdatifan + Cabo has promising activity (manageable AEs) in pts w/ previously treated RCC👇#AlexandraDrakaki @OncoAlert @urotoday @KidneyCAN @KidneyCancer
🚨 Randomized Trial: Significantly less symptom burden with SRS compared to HA-WBRT. SRS Standard of Care for 5-20 brain mets 🚨🚨🚨
We tested the feasibility and immunogenicity of a personalized neoantigen vaccine + PD-L1 blockade in #bladdercancer including the adjuvant setting. nature.com/articles/s4301… @JonAnker1 @BhardwajLab @urotoday @Uromigos @TischCancer @FaltasLab @NatureCancer @BladderCancerUS